Prevention of haemolytic disease of the newborn by anti-D serum given to the mother.
D004899:Erythroblastosis, Fetal / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007116:Immunization, Passive; D007231:Infant, Newborn; D008431:Maternal-Fetal Exchange / Q000502:physiology; D011247:Pregnancy; D012204:Rh-Hr Blood-Group System / Q000009:adverse effects
D012204:Rh-Hr Blood-Group System